2B7J:F:F-iShares MSCI World SRI UCITS ETF USD (Dist) (EUR)

ETF | Others |

Last Closing

USD 8.241

Change

0.00 (0.00)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-18 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

N/A

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.22 (-0.43%)

USD 108.20B
SXR8:F iShares Core S&P 500 UCITS ETF..

-1.06 (-0.20%)

USD 93.32B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 86.92B
SXRZ:F iShares VII PLC - iShares Nikk..

-3.05 (-1.31%)

USD 53.24B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.14 (+0.14%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

N/A

USD 51.63B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.23 (-1.56%)

USD 51.19B
XJSE:F Xtrackers II - Japan Governmen..

-0.07 (-0.91%)

USD 41.09B
0ZC:F Zscaler Inc

-0.22 (-0.14%)

USD 37.92B

ETFs Containing 2B7J:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.22% 53% F 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.22% 50% F 53% F
Trailing 12 Months  
Capital Gain 22.87% 79% B- 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.87% 76% C+ 65% D
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 5.18% 57% F 59% D-
Dividend Return 5.18% 55% F 52% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.63% 71% C- 91% A-
Risk Adjusted Return 60.02% 71% C- 77% C+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike